Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
Abstract Hepatocellular carcinoma (HCC) is the most common primary liver cancer with a high mortality rate. It is regarded as a significant public health issue because of its complicated pathophysiology, high metastasis, and recurrence rates. There are no obvious symptoms in the early stage of HCC,...
Spremljeno u:
| Glavni autori: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2024-02-01
|
| Serija: | MedComm |
| Teme: | |
| Online pristup: | https://doi.org/10.1002/mco2.474 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|